(TARS) – Analyst Ratings
-
Tarsus Pharmaceuticals (TARS) PT Raised to $44 at Jefferies, 'Launch Progressing Well'
-
Goldman Sachs Starts Tarsus Pharmaceuticals (TARS) at Neutral
-
-
-
-
-
-
-
-
-
-
-
Back to TARS Stock Lookup